Basics |
Bioventus Inc.
|
IPO Date: |
February 11, 2021 |
Sector: |
Healthcare |
Industry: |
Medical Devices |
Market Cap: |
$433.32M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.23 | 3.25%
|
Avg Daily Range (30 D): |
$0.17 | 2.44%
|
Avg Daily Range (90 D): |
$0.20 | 2.29%
|
Institutional Daily Volume |
Avg Daily Volume: |
.32M |
Avg Daily Volume (30 D): |
.37M |
Avg Daily Volume (90 D): |
.29M |
Trade Size |
Avg Trade Size (Sh.): |
99 |
Avg Trade Size (Sh.) (30 D): |
68 |
Avg Trade Size (Sh.) (90 D): |
60 |
Institutional Trades |
Total Inst.Trades: |
174 |
Avg Inst. Trade: |
$1.42M |
Avg Inst. Trade (30 D): |
$.61M |
Avg Inst. Trade (90 D): |
$.79M |
Avg Inst. Trade Volume: |
.16M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.65M |
Avg Closing Trade (30 D): |
$.62M |
Avg Closing Trade (90 D): |
$.82M |
Avg Closing Volume: |
182.77K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-.48
|
$-.04
|
$
|
Diluted EPS
|
$-.48
|
$-.04
|
$
|
Revenue
|
$ 567.7M
|
$ 123.88M
|
$ 153.64M
|
Gross Profit
|
$ 382.9M
|
$ 83.06M
|
$ 102.66M
|
Net Income / Loss
|
$ -41.17M
|
$ -3.32M
|
$ -.32M
|
Operating Income / Loss
|
$ -12.44M
|
$ 4.87M
|
$ 7.99M
|
Cost of Revenue
|
$ 184.8M
|
$ 40.82M
|
$ 50.99M
|
Net Cash Flow
|
$ -2.37M
|
$ -18.78M
|
$ -1.49M
|
PE Ratio
|
|
|
|
|